Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15134979 | 0.83 | TGFBR1 (0.42) | TGFBR1ALDH1A1 | |
| SCHEMBL1132239 | 0.80 | TSHR (0.40) | TSHRTGFBR1ALDH1A1HPGDPLA2G2C | |
| SCHEMBL9321557 | 0.80 | TSHR (0.40) | TSHRTGFBR1ALDH1A1HPGDMAPT | |
| SCHEMBL18660317 | 0.79 | TSHR (0.41) | TSHRTGFBR1ALDH1A1HPGDMAPT | |
| SCHEMBL7698203 | 0.78 | TGFBR1 (0.45) | TSHRTGFBR1ALDH1A1 | |
| SCHEMBL7172656 | 0.77 | TSHR (0.38) | TSHRTGFBR1ALDH1A1HPGDPLA2G2C | |
| SCHEMBL7171607 | 0.77 | TSHR (0.38) | TSHRTGFBR1ALDH1A1HPGDPLA2G2C | |
| SCHEMBL9316631 | 0.76 | TSHR (0.44) | TSHRTGFBR1ALDH1A1HPGDRECQL | |
| SCHEMBL7695367 | 0.73 | TGFBR1 (0.46) | TSHRTGFBR1ALDH1A1HSD17B10 | |
| SCHEMBL29121384 | 0.73 | TSHR (0.40) | TSHRTGFBR1ALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239922-A1 | PHOTOCURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240191003-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
| US-20240192593-A1 | PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
| US-11981794-B2 | Curable composition, cured product, and compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-05-14 | — | — | US | disclosed |
| US-20240141085-A1 | PHOTOCURABLE LIQUID COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-05-02 | — | — | US | disclosed |
| US-11926681-B2 | Curable composition, cured product, and method for producing cured product | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-03-12 | — | — | US | disclosed |
| EP-4317196-A1 | PHOTOCURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-02-07 | — | — | EP | disclosed |
| EP-4293052-A1 | PHOTOCURABLE LIQUID COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-12-20 | — | — | EP | disclosed |
| EP-4293051-A1 | PHOTOCURABLE LIQUID COMPOSITION, CURED OBJECT, AND METHOD FOR PRODUCING CURED OBJECT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-12-20 | — | — | EP | disclosed |
| US-20230292468-A1 | RADIATION SHEET, HEAT DISSIPATION PLATE, HEAT DISSIPATION DEVICE AND CURABLE PASTE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-09-14 | — | — | US | disclosed |
| EP-2980059-A1 | VINYL-GROUP-CONTAINING FLUORENE COMPOUND | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2016-02-03 | — | — | EP | disclosed |
| US-9244346-B2 | Negative-type photosensitive resin composition, pattern forming method, cured film, insulating film, color filter, and display device | TOKYO OHKA KOGYO CO., LTD. (JP) | 2016-01-26 | — | — | US | disclosed |
| US-20140231729-A1 | NEGATIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, CURED FILM, INSULATING FILM, COLOR FILTER, AND DISPLAY DEVICE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-20140221649-A1 | NOVEL COMPOUND | DAICEL CORPORATION (JP) | 2014-08-07 | — | — | US | disclosed |
| EP-2725011-A1 | NOVEL COMPOUND | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2014-04-30 | — | — | EP | disclosed |
| EP-2725423-A1 | NEGATIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, CURED FILM, INSULATING FILM, COLOR FILTER, AND DISPLAY DEVICE | Tokyo Ohka Kogyo Co., Ltd. (JP) | 2014-04-30 | — | — | EP | disclosed |
| US-20130241092-A1 | FILM-FORMING COMPOSITION FOR OPTICAL IMPRINT AND METHOD FOR PRODUCING OPTICAL MEMBER | TOKYO OHKA KOGYO CO., LTD. (JP) | 2013-09-19 | — | — | US | disclosed |
| US-8389204-B2 | Method for producing comb-shaped electrode | TOKYO OHKA KOGYO CO., LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| US-20110256484-A1 | METHOD FOR PRODUCING COMB-SHAPED ELECTRODE | TOKYO METROPOLITAN UNIVERSITY (JP) | 2011-10-20 | — | — | US | disclosed |
| US-20080119581-A1 | Material for Metallic-Pattern Formation, Crosslinking Monomer, and Method of Forming Metallic Pattern | TOKYO OHKA KOGYO CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240192593-A1 | PHOTOSENSITIVE COMPOSITION | PPOX, ERCC1, ERCC5 | TSHR 4858/4885TGFBR1 3597/4885ALDH1A1 1414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.